Atlas Trials

Use of Metformin to Reduce Cardiac Toxicity in Breast Cancer

Clinical trial NCT02472353 · TERMINATED

Trial details

NCT number
NCT02472353
Sponsor
Avera McKennan Hospital & University Health Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerBreast Tumors
Start date
2014-07-01
Primary completion
2018-05-23
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.